Sodium;2-sulfanylethanesulfonic acid
- sodium;2-sulfanylethanesulfonic acid
- Mistabronco
- NSC113891
- SR-01000760524
- Pharmakon1600-01502014
- Create:2007-12-05
- Modify:2024-12-28
- 2 Mercaptoethanesulfonate
- 2-Mercaptoethanesulfonate
- 2-Mercaptoethanesulphonate, Sodium
- ASTA D 7093
- ASTA-D 7093
- ASTAD 7093
- Coenzyme M
- Ethanesulfonic acid, 2-mercapto-, monosodium salt
- Mesna
- MESNA cell
- MESNA-cell
- Mesnex
- Mesnum
- Mistabron
- Mistabronco
- Mitexan
- Mucofluid
- Sodium 2-Mercaptoethanesulphonate
- UCB 3983
- UCB-3983
- UCB3983
- Uromitexan
- Ziken
◉ Summary of Use during Lactation
No information is available on the clinical use of mesna during breastfeeding. Because it is used with toxic drugs such as ifosfamide, the manufacturer recommends to not breastfeed during treatment and for 1 week after the last dose of mesna or ifosfamide.
◉ Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
◉ Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
- Drugs and Lactation Database (LactMed)
- DTP/NCILICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuse
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlProtective Agentshttps://www.ncbi.nlm.nih.gov/mesh/68020011
- PubChem